Possible role of P-glycoprotein in cyclophosphamide resistance of transplanted mouse RLS lymphosarcoma

Bulletin of Experimental Biology and Medicine

Volumn 139, Issue 5, 2005, Pages 611-614

  Grishanova, A Yu ^a   Mel'nikova, E V ^a   Kaledin, V I ^b   Nikolin, V P ^b   Lyakhovich, V V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Apoptosis; Cyclophosphamide; Mouse lymphosarcoma; P glycoprotein; Resistance

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DNA FRAGMENT; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL CYCLE G2 PHASE; CELL DIVISION; CONTROLLED STUDY; DNA DETERMINATION; DRUG SENSITIVITY; GENE EXPRESSION; LYMPHOSARCOMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRAIN DIFFERENCE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CYCLOPHOSPHAMIDE; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; LYMPHOMA, DIFFUSE; MALE; MICE; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 24344473749     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-005-0358-3     Document Type: Article

References (15)

1. A. Yu. Grishanova, V. I. Kaledin, T. V. Zueva, et al., Biomed. Khim., 49, 27-34 (2003). 14569871
2. V. I. Kaledin, V. P. Nikolin, T. A. Ageeva, et al., Vopr. Onkol., 46, 588-593 (2000). 11202193
3. A. A. Stavrovskaya, Biokhimiya, 65, 112-126 (2000).
4. E. H. Abraham, A. G. Prat, L. Gerweek, et al., Proc. Natl. Acad. Sci. USA, 90, 312-316 (1993). 7678345
5. C. Bezombes, N. Maestre, G. Laurent, et al., FASEB J., 12, 101-109 (1998). 9438415
6. P. Chomczynski and N. Sacchi, Anal. Biochem., 162, 156-159 (1987). 2440339
7. Y. Eguchi, A. Srinivasan, K. Tomaselli, et al., Cancer Res., 59, 2174-2181 (1999). 10232605
8. Y. A. Hannun, Science, 274, 1855-1865 (1996). 10.1126/ science.274.5294.1855
9. S. Huet, J. P. Marie, N. Gualde, et al., Cytometry, 15, 248-256 (1998). 10.1002/ (SICI)1097-0320(19981215)34:6<248::AID-CYTO2>3.0.CO;2-X
10. X. Jiang and X. Wang, Annu. Rev. Biochem., 73, 87-106 (2004). 10.1146/ annurev.biochem.73.011303.073706
11. R. W. Johnstone, A. A. Ruefli, K. M. Tainton, and M. J. Smyth, Leuk. Lymphoma, 38, 1-11 (2000). 10811443
12. C. J. Matheny, M. W. Lamb, K. L. R. Brouwer, and G. M. Pollack, Pharmacotherapy, 21, 778-796 (2001). 10.1592/phco.21.9.778.34558
13. A. Rebollo, J. Gomej, A. Martinez de Aragon, et al., Exp. Cell Res., 218, 581-585 (1995). 10.1006/excr.1995.1195
14. P. D. Roepe, L. Y. Wei, J. Cruz, and D. Carlson, Biochemistry, 32, 11,042-11,056 (1993).
15. A. van Helvoort, A. J. Smith, H. Sprong, et al., Cell, 87, 507-517 (1996). 10.1016/S0092-8674(00)81370-7